These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17213813)

  • 1. Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments.
    Karagiannis TC; Harikrishnan KN; El-Osta A
    Oncogene; 2007 Jun; 26(27):3963-71. PubMed ID: 17213813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases.
    Bártová E; Pacherník J; Harnicarová A; Kovarík A; Kovaríková M; Hofmanová J; Skalníková M; Kozubek M; Kozubek S
    J Cell Sci; 2005 Nov; 118(Pt 21):5035-46. PubMed ID: 16254244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments.
    Harikrishnan KN; Karagiannis TC; Chow MZ; El-Osta A
    Cell Cycle; 2008 Feb; 7(4):468-76. PubMed ID: 18239454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional cell growth confers radioresistance by chromatin density modification.
    Storch K; Eke I; Borgmann K; Krause M; Richter C; Becker K; Schröck E; Cordes N
    Cancer Res; 2010 May; 70(10):3925-34. PubMed ID: 20442295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
    Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
    Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization to UV-induced apoptosis by the histone deacetylase inhibitor trichostatin A (TSA).
    Kim MS; Baek JH; Chakravarty D; Sidransky D; Carrier F
    Exp Cell Res; 2005 May; 306(1):94-102. PubMed ID: 15878336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors promote the tumoricidal effect of HAMLET.
    Brest P; Gustafsson M; Mossberg AK; Gustafsson L; Duringer C; Hamiche A; Svanborg C
    Cancer Res; 2007 Dec; 67(23):11327-34. PubMed ID: 18056459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
    Chung YL; Lee MY; Pui NN
    Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of chromatin structure modulation by the histone deacetylase inhibitor trichostatin A on the radio-sensitivity of ataxia telangiectasia.
    Meschini R; Morucci E; Berni A; Lopez-Martinez W; Palitti F
    Mutat Res; 2015 Jul; 777():52-9. PubMed ID: 25942615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin changes induced by lamin A/C deficiency and the histone deacetylase inhibitor trichostatin A.
    Galiová G; Bártová E; Raska I; Krejcí J; Kozubek S
    Eur J Cell Biol; 2008 May; 87(5):291-303. PubMed ID: 18396346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines.
    Ou JN; Torrisani J; Unterberger A; Provençal N; Shikimi K; Karimi M; Ekström TJ; Szyf M
    Biochem Pharmacol; 2007 May; 73(9):1297-307. PubMed ID: 17276411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases.
    Taddei A; Maison C; Roche D; Almouzni G
    Nat Cell Biol; 2001 Feb; 3(2):114-20. PubMed ID: 11175742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase 3 represses HTLV-1 tax transcription.
    Villanueva R; Iglesias AH; Camelo S; Sanin LC; Gray SG; Dangond F
    Oncol Rep; 2006 Sep; 16(3):581-5. PubMed ID: 16865259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichostatin-A induces differential changes in histone protein dynamics and expression in HeLa cells.
    Rao J; Bhattacharya D; Banerjee B; Sarin A; Shivashankar GV
    Biochem Biophys Res Commun; 2007 Nov; 363(2):263-8. PubMed ID: 17869223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin induces apoptosis with profile of large-scale DNA fragmentation and without DNA ladder in anaplastic thyroid carcinoma cells via histone hyperacetylation.
    Rho JH; Kang DY; Park KJ; Choi HJ; Lee HS; Yee SB; Yoo YH
    Int J Oncol; 2005 Aug; 27(2):465-71. PubMed ID: 16010429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone modification in constitutive heterochromatin versus unexpressed euchromatin in human cells.
    Jiang G; Yang F; Sanchez C; Ehrlich M
    J Cell Biochem; 2004 Oct; 93(2):286-300. PubMed ID: 15368356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond repair foci: DNA double-strand break repair in euchromatic and heterochromatic compartments analyzed by transmission electron microscopy.
    Lorat Y; Schanz S; Schuler N; Wennemuth G; Rübe C; Rübe CE
    PLoS One; 2012; 7(5):e38165. PubMed ID: 22666473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibition redistributes topoisomerase IIβ from heterochromatin to euchromatin.
    Cowell IG; Papageorgiou N; Padget K; Watters GP; Austin CA
    Nucleus; 2011; 2(1):61-71. PubMed ID: 21647300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
    Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
    Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.